The authors report the case of a chronic myeloid leukemia (CML) patient submitted to allogenic bone marrow transplantation, who had probably never entered complete remission. The disease was reactivated as a granulocytic sarcoma, next to a platinum plate installed to correct a tibia fracture 11 years earlier. Its final event was a myeloid Ph1+ blastic crisis that was unsuccessfully treated with high doses of sc interferon and citarabine. UNITERMS: Granulocytic sarcoma. Bone marrow transplantation. Chronic myeloid leukemia. Hypercalcemia
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Over the past 60 years, haematologists and scientists from the United Kingdom, notably John Goldman ...
years with a median age of 29, underwent hematopoietic stem cell transplantation. Eighty-eight patie...
The authors report the case of a chronic myeloid leukemia (CML) patient submitted to allogenic bone ...
the editor: No more transplantation in CML? Hehlmann et al1 report that drug treatment is superior t...
lymphocytic leukemia (CLL) published guidelines for the design and conduct of clinical trials for pa...
Therapy-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) is an increasingly recog...
Therapeutic options for advanced B-cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic l...
Abstract: Objective: To evaluate the efficacy of imatinib in chronic myeloid leukemia patients with ...
To the Editor: We share the point that secondary myelodysplasia and secondary acute myelogenous leuk...
aop.sagepub.com Letter to the Editor The aim of this report is to describe a newly diagnosed chronic...
The current treatment of chronic phase chronic myeloid leukemia (CML) consists of oral tyrosine kina...
In this report, we present our experience with 20 patients affected by chronic myelogenous leukaemia...
publisher[Abstract] The prognosis of chronic myeloid leukemia (CML) in chronic phase (CP) have been ...
Despite the initial success of imatinib (Gleevec, STI571) in the treatment of chronic myeloid leukae...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Over the past 60 years, haematologists and scientists from the United Kingdom, notably John Goldman ...
years with a median age of 29, underwent hematopoietic stem cell transplantation. Eighty-eight patie...
The authors report the case of a chronic myeloid leukemia (CML) patient submitted to allogenic bone ...
the editor: No more transplantation in CML? Hehlmann et al1 report that drug treatment is superior t...
lymphocytic leukemia (CLL) published guidelines for the design and conduct of clinical trials for pa...
Therapy-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) is an increasingly recog...
Therapeutic options for advanced B-cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic l...
Abstract: Objective: To evaluate the efficacy of imatinib in chronic myeloid leukemia patients with ...
To the Editor: We share the point that secondary myelodysplasia and secondary acute myelogenous leuk...
aop.sagepub.com Letter to the Editor The aim of this report is to describe a newly diagnosed chronic...
The current treatment of chronic phase chronic myeloid leukemia (CML) consists of oral tyrosine kina...
In this report, we present our experience with 20 patients affected by chronic myelogenous leukaemia...
publisher[Abstract] The prognosis of chronic myeloid leukemia (CML) in chronic phase (CP) have been ...
Despite the initial success of imatinib (Gleevec, STI571) in the treatment of chronic myeloid leukae...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
Over the past 60 years, haematologists and scientists from the United Kingdom, notably John Goldman ...
years with a median age of 29, underwent hematopoietic stem cell transplantation. Eighty-eight patie...